FindTrial
Sign In

High power versus routine power of radiofrequency catheter ablaiton for the treatment of atrial fibrillation, a multi-center prospective randomized control study

High power versus routine power of radiofrequency catheter ablaiton for the treatment of atrial fibrillation, a multi-center prospective randomized control study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037769
Enrollment
Unknown
Registered
2020-08-31
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

high power ablation group:high power ablation
Conventional group:25-30W conventional power

Sponsors

Department of Cardiology, Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. paroxysmal atria fibrillation; 2. severe symptom; 3. refractory to Class Ic or III anti-arrhythmia medication; 4. Aged 18-75 years old male and female.

Exclusion criteria

Exclusion criteria: 1. mitral valve disease; 2. heart failure,LVEF less than 35%; 3. severe coronary disease; 4. left atrial thrombus; 5. pulmonary hypertension; 6. severe hypertension; 7. thyroid disfunction; 8. history stroke in 6-12 months; 9. hypersensitivity to warfarin or other anti-thrombus medication; 10. severe liver or kidney function; 11. cancer; 12. pregnancy.

Design outcomes

Primary

MeasureTime frame
successful rate of pulmonary vein isolation in single ablation procedure;—

Contacts

Public ContactTang Kai

Department of Cardiology, Shanghai Tenth People's Hospital

1200025@tongji.edu.cn+86 18917684050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026